ArticleScience advances2026

TCR-JANUS engager proteins enable bispecific targeting to overcome tumor heterogeneity in TCR-T cell therapy.

Chenxi Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.